Timelines

Three girls die before their 21st birthdays. Kayleigh, 19, a victim in a fatal car accident; Amber, 16, bullied into taking her own life; and Jenna, 20, lost a fight with a rare disease. Soon after, their stories go viral and the world is given access to their lives and deaths.

Kayleigh wrote a bucket list that was shared the world over after her death, inspiring thousands of strangers to live her dreams. Amber seemed to have it all, her suicide sent shockwaves through her small town, questions are asked and a portrait of online bullying and torment emerge. Jenna is diagnosed with a disease so rare that doctors didn’t know how to treat it, turning to social media to find support and raise awareness, her campaign ‘Get Me to 21’ makes her a star, and saves lives but sadly not her own.

Timelines is a documentary about three young girls who lived and died on the internet, a story about grief in the digital age and how personas are shaped online. And for the families the question remains, how do you say goodbye, when death goes viral?

Timelines from Sideways Film on Vimeo.

The God Cells: A Fetal Stem Cell Journey

Stem Cell research and therapy have been growing at a rapid rate over the past fifteen years. Scientific advances coupled with consumer demand have proven that stem cell therapy is the wave of the future, and is poised to change the face of medicine.

The only hurdles have been religious and regulatory roadblocks slowing down the approval process for fetal stem cell therapy, arguably the most contested and controversial form of stem cell therapy to date, due to them being harvested from abortions.

The God Cells takes the audience on a journey with those who seek the life changing fetal stem cell therapy abroad, while avoiding the seemingly insurmountable roadblocks at home.

“The demand is real, patients with current unmet medical needs are desperate and require this therapy, but the current regulatory and industry hurdles are making it near impossible for us to do our job and get these important stem cell therapies to those people in need. Because of this, many scientific organizations are taking their technology abroad to appease patient demand, because they feel the current regulatory hurdles are insurmountable.”

Randal Mills, PhD, President and CEO for California Institute For Regenerative Medicine